Equity Overview
Price & Market Data
Price: $111.0
Daily Change: $0.00 / 0.00%
Range: $111.0 - $111.0
Market Cap: $26,352,066,560
Volume: 430
Performance Metrics
1 Week: -0.51%
1 Month: -9.92%
3 Months: 11.44%
6 Months: 31.83%
1 Year: 40.19%
YTD: -9.92%
Details
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.